These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6967385)

  • 1. Inability of patients with common variable hypogammaglobulinemia to generate lymphjoblastoid B cells following booster immunization.
    Stevens RH; Tamaroff M; Saxon A
    Clin Immunol Immunopathol; 1980 Jul; 16(3):336-43. PubMed ID: 6967385
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of a circulating subpopulation of spontaneous antitetanus toxoid antibody producing B cells following in vivo booster immunization.
    Stevens RH; Macy E; Morrow C; Saxon A
    J Immunol; 1979 Jun; 122(6):2498-504. PubMed ID: 312871
    [No Abstract]   [Full Text] [Related]  

  • 3. Impaired generation of spontaneous and mitogen-reactive antitetanus toxoid antibody-producing B cells following repetitive in vivo booster immunization.
    Saxon A; Tamaroff MA; Morrow C; Stevens RH
    Cell Immunol; 1981 Mar; 59(1):82-96. PubMed ID: 6971181
    [No Abstract]   [Full Text] [Related]  

  • 4. Differential synthesis of IgM and IgA anti-tetanus toxoid antibody in vitro following in vivo booster immunization of humans.
    Stevens RH; Saxon A
    Cell Immunol; 1979 Jun; 45(1):142-50. PubMed ID: 455480
    [No Abstract]   [Full Text] [Related]  

  • 5. Age-related decrease in frequencies of B-cell precursors and specific helper T cells involved in the IgG anti-tetanus toxoid antibody production in humans.
    Kishimoto S; Tomino S; Mitsuya H; Nishimura H
    Clin Immunol Immunopathol; 1982 Oct; 25(1):1-10. PubMed ID: 6217937
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunoregulation in humans: control of antitetanus toxoid antibody production after booster immunization.
    Stevens RH; Saxon A
    J Clin Invest; 1978 Dec; 62(6):1154-60. PubMed ID: 311781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody synthesis by bone marrow cells in vitro following primary and booster tetanus toxoid immunization in humans.
    Kodo H; Gale RP; Saxon A
    J Clin Invest; 1984 May; 73(5):1377-84. PubMed ID: 6609170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of "acquired" or common variable agammaglobulinemia.
    Geha RS; Schneeberger E; Merler E; Rosen FS
    N Engl J Med; 1974 Jul; 291(1):1-6. PubMed ID: 4545549
    [No Abstract]   [Full Text] [Related]  

  • 9. Specific in vivo and in vitro antibody response to tetanus toxoid immunization.
    Ershler WB; Moore AL; Hacker MP
    Clin Exp Immunol; 1982 Sep; 49(3):552-8. PubMed ID: 6756720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific anti-influenza virus antibody production in vitro by lymphocytes from a subset of patients with hypogammaglobulinemia.
    Yarchoan R; Schneider HS; Wray BB; Nelson DL
    J Clin Invest; 1983 Jun; 71(6):1720-7. PubMed ID: 6863541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective generation of tetanus-specific antibody-producing B cells after in vivo immunization of Crohn's disease and ulcerative colitis patients.
    Stevens R; Oliver M; Brogan M; Heiserodt J; Targan S
    Gastroenterology; 1985 Jun; 88(6):1860-6. PubMed ID: 3873371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of auto-anti-idiotypic antibody during the normal human immune response to tetanus toxoid antigen.
    Geha RS
    J Immunol; 1982 Jul; 129(1):139-44. PubMed ID: 7086128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The induction and suppression of in vitro IgG anti-tetanus toxoid antibody synthesis by human lymphocytes stimulated with tetanus toxoid in the absence of in vivo booster immunizations.
    Lum LG; Culbertson NJ
    J Immunol; 1985 Jul; 135(1):185-91. PubMed ID: 2582031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immature B cells in fetal development and immunodeficiency: studies of IgM, IgG, IgA and IgD production in vitro using Epstein-Barr virus activation.
    Pereira S; Webster D; Platts-Mills T
    Eur J Immunol; 1982 Jul; 12(7):540-6. PubMed ID: 6288397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient immunoglobulin and antibody production. Occurrence in two patients with common varied immunodeficiency.
    Zielinski CC; Mutschlechner R; Schwarz G; Eibl MM
    Arch Intern Med; 1983 Oct; 143(10):1937-40. PubMed ID: 6605128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human anti-tetanus antibody response in vitro: autologous and allogeneic T cells provide help by different routes.
    Brenner MK; Munro AJ
    Clin Exp Immunol; 1981 Oct; 46(1):171-7. PubMed ID: 6978212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related decline in the in vitro and in vivo syntheses of anti-tetanus toxoid antibody in humans.
    Kishimoto S; Tomino S; Mitsuya H; Fujiwara H; Tsuda H
    J Immunol; 1980 Nov; 125(5):2347-52. PubMed ID: 6968781
    [No Abstract]   [Full Text] [Related]  

  • 18. Dynamics of human circulating antigen reactive cells following secondary immunization with tetanus toxoid.
    Geha RS
    Clin Immunol Immunopathol; 1981 May; 19(2):196-205. PubMed ID: 6971719
    [No Abstract]   [Full Text] [Related]  

  • 19. Presence of circulating anti-idiotype-bearing cells after booster immunization with tetanus toxoid (TT) and inhibition of anti-TT antibody synthesis by auto-anti-idiotypic antibody.
    Geha RS
    J Immunol; 1983 Apr; 130(4):1634-9. PubMed ID: 6601133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary immunization with a protein antigen (tetanus toxoid) in man. Characterization of humoral and cell-mediated regulatory events.
    Donnenberg AD; Elfenbein GJ; Santos GW
    Scand J Immunol; 1984 Oct; 20(4):279-89. PubMed ID: 6209787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.